MBL International Competitors and Similar CompaniesClear all
MBL International's competitors and similar companies include Eurobio Scientific, Urogen Pharma and Viracta Therapeutics.
 MBL International MBL International is a life science company providing solutions for researchers in the life sciences, drug discovery and development, and clinical diagnostics fields. |  Eurobio Scientific Eurobio Scientific is a company that develops, produces, and markets reagents for research and biomedical diagnosis. |  Viracta Therapeutics Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients with viral-associated cancers and other serious diseases. | ||
Founding Date | Founding Date 1993 | Founding Date 1997 | Founding Date 2004 | Founding Date 2016 |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Woburn, US HQ | Locations Les Ulis, FR HQ Rockville, US | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations Encinitas, US HQ |
Employees | Employees 753% decrease | Employees 1154% increase | Employees 194362% increase | Employees 323% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 279.9 m | Valuation ($) 515.9 m | Valuation ($) 8.7 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €168.3m (FY, 2025) | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €78.9m (FY, 2025) | Cost of goods $12.4m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €89.7m (FY, 2025) | Gross profit $97.3m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income €4.9m (FY, 2025) | Net income ($153.5m) (FY, 2025) | Net income ($51.1m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Eurobio Scientific
HQ
Les Ulis, FR
Employees
115↑ 4% increase
Eurobio Scientific is a company that develops, produces, and markets reagents for research and biomedical diagnosis.
View company
Urogen Pharma
HQ
New York, US
Employees
194
UroGen Pharma is a clinical-stage biopharmaceutical company.
View companyViracta Therapeutics
HQ
Encinitas, US
Employees
32↑ 3% increase
Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients with viral-associated cancers and other serious diseases.
View company